Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 1stDecember 2014
Summary The industry analysis specialist, has released its new report, “Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Psychotic Depression Therapeutics market. The report identifies the key trends shaping and driving the global Psychotic Depression Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Psychotic Depression Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-psychotic-depression-therapeutics-pipeline-assessment-and-marketforecasts-135216 Scope The report provides information on the key drivers and challenges of the Psychotic Depression Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Psychotic Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Depression Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Psychotic Depression Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Psychotic Depression Therapeutics market. - Analysis of key recent licensing and partnership agreements in Psychotic Depression Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Psychotic Depression Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Psychotic Depression Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Psychotic Depression Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Psychotic Depression Therapeutics - Introduction 2.1 Disease Overview 2.2 Epidemiology 2.2.1 Prevalence 2.2.2 Quality of Life 2.2.3 Economic Burden 2.2.4 Mortality 2.3 Etiology and Pathophysiology 2.4 Signs and Symptoms 2.5 Diagnosis 2.5.1 DSM-IV-TR Diagnostic Criteria for Major Depressive Episode 2.5.2 DSM-IV-TR Diagnostic Criteria for Major Depressive Episode, Severe with Psychotic Features 2.5.3 Rating Scales 2.6 Treatment and Management Options 2.6.1 Electroconvulsive Therapy (ECT) 2.6.2 Pharmacotherapy 2.6.3 Other Treatments Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.7 Limitation for Study of Psychotic Depression 2.8 Referral Pathway 2.9 GlobalData Pipeline Report Guidance 3 Psychotic Depression Therapeutics - Market Characterization 3.1 Overview 3.2 Psychotic Depression Therapeutics Market Size (2006-2011) - Global 3.3 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Global 3.4 Psychotic Depression Therapeutics Market Size (2006-2011) - The US 3.5 Psychotic Depression Therapeutics Market Forecast (2011-2019) - The US 3.6 Psychotic Depression Therapeutics Market Size (2006-2011) - France 3.7 Psychotic Depression Therapeutics Market Forecast (2011-2019) - France 3.8 Psychotic Depression Therapeutics Market Size (2006-2011) - Germany 3.9 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Germany 3.10 Psychotic Depression Therapeutics Market Size (2006-2011) - Italy 3.11 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Italy 3.12 Psychotic Depression Therapeutics Market Size (2006-2011) - Spain 3.13 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Spain 3.14 Psychotic Depression Therapeutics Market Size (2006-2011) - The UK 3.15 Psychotic Depression Therapeutics Market Forecast (2011-2019) - The UK 3.16 Psychotic Depression Therapeutics Market Size (2006-2011) - Japan 3.17 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Japan 3.18 Drivers and Barriers for the Psychotic Depression Therapeutics Market 3.18.1 Drivers for the Psychotic Depression Therapeutics Market 3.18.2 Barriers for the Psychotic Depression Therapeutics Market 3.19 Opportunity and Unmet Need Analysis 3.20 Key Takeaway 4 Psychotic Depression Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Off-label Marketed Products in the Psychotic Depression Market 4.3.1 Antidepressants 4.3.2 Antipsychotics 4.3.3 Mood Stabilizers (Lithium) 4.4 Key Takeaway 5 Psychotic Depression Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Psychotic Depression Therapeutics Pipeline - Pipeline by Phases of Development Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.3.1 Psychotic Depression Therapeutics - Phase III Pipeline 5.4 Psychotic Depression Therapeutics Market - Pipeline by Mechanism of Action 5.5 Technology Trends Analytic Framework 5.6 Molecule Profile for Promising Drug Under Development 5.6.1 Korlym (mifepristone) 5.7 Key Takeaway 6 Psychotic Depression Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Overall Sponsors 6.5 Prominent Sponsors 6.6 Top Companies Participating in Psychotic Depression Therapeutics Clinical Trials 7 Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Psychotic Depression Therapeutics - Implications for Future Market Competition 8 Psychotic Depression Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Corcept Therapeutics Incorporated 9 Psychotic Depression Therapeutics - Appendix 9.1 Market Definitions 9.2 Abbreviations 9.3 Methodology 9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting 9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography
List Of Tables Table 1: Psychotic Depression Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 2: Psychotic Depression Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 3: Psychotic Depression Therapeutics Market, The US, Revenue ($m), 2006-2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 4: Psychotic Depression Therapeutics Market, The US, Forecast ($m), 2011-2019 Table 5: Psychotic Depression Therapeutics Market, France, Revenue ($m), 2006-2011 Table 6: Psychotic Depression Therapeutics Market, France, Forecast ($m), 2011-2019 Table 7: Psychotic Depression Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 8: Psychotic Depression Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 9: Psychotic Depression Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 10: Psychotic Depression Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 11: Psychotic Depression Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 12: Psychotic Depression Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 13: Psychotic Depression Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 14: Psychotic Depression Therapeutics Market, The UK, Forecast ($m), 2011-2019 Table 15: Psychotic Depression Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 16: Psychotic Depression Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 17: Psychotic Depression Therapeutics, Phase III Pipeline, 2011 Table 18: Psychotic Depression Therapeutics, Clinical Trials by Country, 2011 Table 19: Psychotic Depression Therapeutics, Clinical Trials by Phase, 2011 Table 20: Psychotic Depression Therapeutics, Clinical Trials by Status of Development, 2011 Table 21: Psychotic Depression Therapeutics, Clinical Trials by Overall Sponsors, 2011 Table 22: Psychotic Depression Therapeutics, Prominent Sponsors, 2011 Table 23: Psychotic Depression Therapeutics, Top Companies Participating in Therapeutics Clinical Trials, 2011 Table 24: Corcept Therapeutics Incorporated - Pipeline, 2011 Table 25: Corcept Therapeutics Incorporated - Psychotic Depression Pipeline, 2011
List Of Figures Figure 1: DSM-IV-TR Diagnostic Criteria for Major Depressive Episode Figure 2: DSM-IV-TR Diagnostic Criteria for Major Depressive Episode, Severe with Psychotic Features Figure 3: Treatment Algorithm for Psychotic Depression Figure 4: Psychotic Depression Therapeutics - Referral Pathway Figure 5: Psychotic Depression Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 6: Psychotic Depression Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 7: Psychotic Depression Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 8: Psychotic Depression Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 9: Psychotic Depression Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 10: Psychotic Depression Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 11: Psychotic Depression Therapeutics Market, Germany, Revenue ($m), 2006-2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 12: Psychotic Depression Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 13: Psychotic Depression Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 14: Psychotic Depression Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 15: Psychotic Depression Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 16: Psychotic Depression Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 17: Psychotic Depression Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 18: Psychotic Depression Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 19: Psychotic Depression Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 20: Psychotic Depression Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 21: Psychotic Depression Therapeutics, Strategic Competitor Assessment, 2011 Figure 22: Psychotic Depression Therapeutics, Technology Trends Analytics Framework, 2011 Figure 23: Psychotic Depression Therapeutics, Technology Trends Analytics Framework, Description, 2011 Figure 24: Structure of Korlym Figure 25: Psychotic Depression Therapeutics, Clinical Trials by Country, 2011 Figure 26: Psychotic Depression Therapeutics, Clinical Trials by Status of Development (%), 2011 Figure 27: Psychotic Depression Therapeutics Market, Drivers and Restraints, 2011 Figure 28: Implications for Future Market Competition in the Psychotic Depression Market, 2011 Figure 29: Psychotic Depression Therapeutics Market, Pipeline by Company, 2011 Figure 30: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Addisons Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019 Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-psychoticdepression-therapeutics-pipeline-assessment-and-market-forecasts-135216
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/